Condition: OMI - Occlusion Myocardial Infarction · Artificial Intelligence (AI) · Electrocardiogram · Sponsor: National Defense Medical Center, Taiwan
This trial will prospectively evaluate the impact of integrating AI-ECG within the pay-for-performance program on improving the diagnosis, treatment, and clinical outcomes of occlusion myocardial infarction patients by promoting accurate and timely diagnoses through financial incentives.
This description comes directly from the study's public registry record.
Chin Lin, PhD · +886-2-8792-3100 · xup6fup@mail.ndmctsgh.edu.tw
Always discuss trial participation with your own doctor first.
| Kaohsiung Armed Forces General Hospital | Kaohsiung City, Taiwan, Taiwan | Recruiting |
| Taipei Municipal Wanfang Hospital | Taipei, Taiwan | Recruiting |
| Tri-Service General Hospital | Taipei, Taiwan | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06887699